Artificial heart launch imminent
This article was originally published in The Gray Sheet
Executive Summary
Abiomed plans to launch its AbioCor artificial heart in four to five U.S. hospitals in the next several months now that the firm has gained supplemental approval from FDA for upgrades to the humanitarian use device. The product was awarded a humanitarian device exemption in September 2006 for biventricular heart failure support in patients not eligible for a transplant (1"The Gray Sheet" Sept. 11, 2006, p. 9)
You may also be interested in...
CMS Proposes Coverage With Evidence Development For Artificial Hearts
CMS is proposing to pay for artificial hearts for the first time in 22 years, but only in certain clinical trials
AbioCor Artificial Heart Gets FDA Humanitarian Device Exemption
The first fully implantable artificial heart, more than 25 years in the making, received approval from FDA Sept. 5 as a humanitarian-use device
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.